Boston-A gene that plays a role in the development of breast cancer to metastatic disease has been identified which may help to predict disease progression and serve as a target for the development of future breast cancer ...
Jan 7, 2016
0
20
Surgical castration to remove the testicles (orchiectomy) of men with metastatic prostate cancer was associated with lower risks for adverse effects compared with men who underwent medical castration with gonadotropin-releasing ...
Dec 23, 2015
0
0
Among patients with HER2-positive, metastatic breast cancer that had progressed despite treatment with two or more forms of HER2-targeted therapy (trastuzumab [Herceptin] and lapatinib [Tykerb]), median overall survival was ...
Dec 11, 2015
0
0
An ongoing phase IIR/III clinical trial presented at the 2015 San Antonio Breast Cancer Symposium seeks to answer an important question in the treatment of early metastatic breast cancer: Should surgery or stereotactic body ...
Dec 8, 2015
0
36
For patients with colorectal cancer enrolled in a phase I clinical trial, response to the combination treatment being tested and disease progression were accurately tracked by quantifying levels of the BRAF V600E genetic ...
Nov 9, 2015
0
3
The capacity of cancer cells to spread throughout the body and invade new tissues — to become metastatic — makes them deadly. What makes metastatic cells different?
Oct 2, 2015
0
11
As the field of liquid biopsies for tracking disease progression and therapeutic response heats up, many doctors are looking for ways to apply this approach to their patients. Currently, assays for circulating tumor cells ...
Sep 24, 2015
0
5
Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response ...
Jul 23, 2015
0
14
Patients with metastatic colorectal cancer (mCRC) that are mutation-free in the KRAS, NRAS, BRAF and PIK3CA genes showed significant benefit from continuing anti-epidermal growth factor receptor (EGFR) therapy beyond progression ...
Jul 4, 2015
0
7
An international research team led by Mayo Clinic oncologists has found a new way to identify and possibly stop the progression of many late-stage cancers, including bladder, blood, bone, brain, lung and kidney.
Jun 17, 2015
0
74
